Drug Discovery & Development: A Step-by-Step Academic Guide

Added:

Phenotypic Drug Discovery (PDD)

While traditional academic guides heavily emphasize the target-based drug discovery (TBDD) paradigm—which begins by identifying a specific molecular target and designing compounds to interact with it—an influential counter-perspective champions Phenotypic Drug Discovery (PDD). PDD bypasses initial target identification, instead screening chemical compounds in cell-based assays or animal models to observe desirable therapeutic effects first, identifying the molecular target only later, if at all. Proponents of PDD argue that target-based discovery is overly reductionist and a major driver of high clinical failure rates, as biological systems are too complex to be simulated by single-target interactions. Historically, many breakthrough, first-in-class drugs have been discovered phenotypically. This alternative approach challenges the prevailing linear 'target-to-lead' teaching model, introducing students to a holistic, systems-biology perspective that embraces physiological complexity from the outset.

Basic Biochemistry and Molecular Biology: Understanding how proteins, enzymes, and nucleic acids function as cellular receptors and drug targets.
Introduction to Pharmacology: Familiarity with the concepts of pharmacodynamics (how drugs affect the body) and pharmacokinetics (how the body processes drugs via ADME).
Cell Biology and Pathophysiology: Comprehending normal cellular signaling pathways and how disease states disrupt these mechanisms.
Organic Chemistry: Knowledge of chemical structures, functional groups, and molecular binding forces that dictate drug-receptor interactions.
Computer-Aided Drug Design (CADD): Utilizing bioinformatics, molecular docking, and machine learning for in silico drug discovery and lead optimization.
Clinical Trial Design and Biostatistics: Exploring the statistical methods, protocol design, and ethical considerations required for Phase I-IV human clinical trials.
Advanced Drug Delivery Systems: Studying nanotechnology, formulation science, and targeted therapies like antibody-drug conjugates.
Regulatory Science and Pharmacovigilance: Investigating global regulatory frameworks (FDA, EMA) and post-market safety monitoring of therapeutics.
Pharmacogenomics and Personalized Medicine: Exploring how genomic variations influence individual drug efficacy and toxicity.
7.7K views150likes28:03@VidyamitraOriginal Release: 2018-05-29

The drug discovery and development process is a multi-stage, time-intensive endeavor spanning approximately 8-15 years and costing over $1.5 billion, involving systematic steps from understanding disease mechanisms and identifying molecular targets through preclinical testing to clinical trials (Phase 0-3) and finally regulatory approval, with only about 12% of drugs entering clinical trials ultimately receiving marketing authorization.